Why have it done in China specifically?

China offers aHSCT at approximately $80,000, significantly lower than in the US or Europe, while maintaining internationally accredited stem cell therapy centers with experienced transplant teams. High patient volumes at leading hospitals ensure refined protocols and multidisciplinary support. Combined with streamlined medical visa processes and affordable post-transplant care, China provides a cost-effective yet high-quality option for international patients.